例如:"lncRNA", "apoptosis", "WRKY"

MAM domain containing 2 is a potential breast cancer biomarker that exhibits tumour-suppressive activity.

Cell Prolif. 2020 Sep;53(9):e12883. doi:10.1111/cpr.12883. Epub 2020 Jul 24
Hyeonhee Lee 1 , Bum-Chan Park 2 , Jong Soon Kang 3 , Yeongmi Cheon 4 , Soojin Lee 1 , Pil Jae Maeng 1
Hyeonhee Lee 1 , Bum-Chan Park 2 , Jong Soon Kang 3 , Yeongmi Cheon 4 , Soojin Lee 1 , Pil Jae Maeng 1
+ et al

[No authors listed]

Author information
  • 1 Department of Microbiology and Molecular Biology, Chungnam National University, Daejeon, Republic of Korea.
  • 2 Y-Biologics Inc, Daejeon, Republic of Korea.
  • 3 Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Republic of Korea.
  • 4 Gwangju Center, Korea Basic Science Institute (KBSI), Gwangju, Republic of Korea.

摘要


OBJECTIVES:The aim of this study was to discover new potential biomarkers of breast cancer and investigate their cellular functions. MATERIALS AND METHODS:We analysed the gene expression profiles of matched pairs of breast tumour and normal tissues from 24 breast cancer patients. Tetracycline-inducible MAMDC2 expression system was established and used to evaluate cell proliferation in vitro and in vivo. MAMDC2-mediated signalling was determined using immunoblot analysis. RESULTS:We identified MAMDC2 as a down-regulated gene showing significant prognostic capability. Overexpression of MAMDC2 or treatment with MAMDC2-containing culture medium significantly inhibited the cell proliferation of T-47D cells. Furthermore, MAMDC2 expression reduced in vivo growth of T-47D xenograft tumours. MAMDC2 may exert its growth-inhibitory functions by attenuating the MAPK signalling pathway. CONCLUSION:We report that MAMDC2 has a tumour-suppressive role and, as a secretory protein, it might be useful as a biomarker for breast cancer treatment.

KEYWORDS: biomarkers, breast cancer, cell proliferation, tumour suppressor